$VEEV
VEEVA SYSTEMS INC

2014 Q4 Form 10-Q Financial Statement

#000156459014006187 Filed on December 11, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2013 Q4 2013 Q3
Revenue $83.83M $54.98M $49.58M
YoY Change 52.47% 53.59% 68.33%
Cost Of Revenue $30.42M $21.39M $19.14M
YoY Change 42.18% 34.91% 46.69%
Gross Profit $53.41M $33.59M $30.44M
YoY Change 59.02% 68.44% 85.54%
Gross Profit Margin 63.71% 61.09% 61.39%
Selling, General & Admin $22.83M $17.02M $14.24M
YoY Change 34.18% 125.36% 137.5%
% of Gross Profit 42.75% 50.67% 46.79%
Research & Development $10.64M $6.585M $6.357M
YoY Change 61.5% 82.66% 93.46%
% of Gross Profit 19.91% 19.61% 20.89%
Depreciation & Amortization $400.0K $200.0K $200.0K
YoY Change 100.0% 100.0% 0.0%
% of Gross Profit 0.75% 0.6% 0.66%
Operating Expenses $33.47M $23.60M $20.60M
YoY Change 41.8% 111.56% 121.91%
Operating Profit $19.94M $9.985M $9.838M
YoY Change 99.71% 13.67% 38.14%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$989.0K $125.0K -$65.00K
YoY Change -891.2% 68.92% -84.56%
Pretax Income $18.95M $10.11M $9.773M
YoY Change 87.46% 14.13% 45.84%
Income Tax $8.694M $3.585M $3.775M
% Of Pretax Income 45.87% 35.46% 38.63%
Net Earnings $10.26M $6.525M $5.998M
YoY Change 57.21% 13.5% 41.23%
Net Earnings / Revenue 12.24% 11.87% 12.1%
Basic Earnings Per Share $0.08 $0.07 $0.05
Diluted Earnings Per Share $0.07 $0.05 $0.03
COMMON SHARES
Basic Shares Outstanding 129.2M 35.80M 24.42M
Diluted Shares Outstanding 144.3M 132.0M 37.04M

Balance Sheet

Concept 2014 Q4 2013 Q4 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $392.9M $273.4M $52.90M
YoY Change 43.71%
Cash & Equivalents $262.5M $257.1M $38.61M
Short-Term Investments $260.7M $16.20M $14.30M
Other Short-Term Assets $4.524M $4.635M $4.400M
YoY Change -2.39%
Inventory
Prepaid Expenses
Receivables $45.20M $48.60M $38.90M
Other Receivables $4.800M $100.0K $100.0K
Total Short-Term Assets $449.5M $328.4M $96.30M
YoY Change 36.86%
LONG-TERM ASSETS
Property, Plant & Equipment $27.60M $2.319M $2.100M
YoY Change 1090.17%
Goodwill $4.709M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.959M $1.220M $1.100M
YoY Change 224.51%
Total Long-Term Assets $43.05M $16.84M $16.30M
YoY Change 155.64%
TOTAL ASSETS
Total Short-Term Assets $449.5M $328.4M $96.30M
Total Long-Term Assets $43.05M $16.84M $16.30M
Total Assets $492.6M $345.3M $112.6M
YoY Change 42.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.147M $2.436M $1.300M
YoY Change -11.86%
Accrued Expenses $12.35M $14.11M $11.40M
YoY Change -12.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $107.8M $70.25M $61.20M
YoY Change 53.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.900M $1.882M $1.400M
YoY Change 0.96%
Total Long-Term Liabilities $1.900M $1.882M $1.400M
YoY Change 0.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $107.8M $70.25M $61.20M
Total Long-Term Liabilities $1.900M $1.882M $1.400M
Total Liabilities $111.3M $74.64M $65.20M
YoY Change 49.11%
SHAREHOLDERS EQUITY
Retained Earnings $42.30M
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $381.2M $270.6M $47.40M
YoY Change
Total Liabilities & Shareholders Equity $492.6M $345.3M $112.6M
YoY Change 42.66%

Cashflow Statement

Concept 2014 Q4 2013 Q4 2013 Q3
OPERATING ACTIVITIES
Net Income $10.26M $6.525M $5.998M
YoY Change 57.21% 13.5% 41.23%
Depreciation, Depletion And Amortization $400.0K $200.0K $200.0K
YoY Change 100.0% 100.0% 0.0%
Cash From Operating Activities $34.30M $5.267M $7.300M
YoY Change 551.22% -45.79% 5.8%
INVESTING ACTIVITIES
Capital Expenditures -$900.0K $460.0K $884.0K
YoY Change -295.65% 75.57% -247.33%
Acquisitions $12.15M
YoY Change
Other Investing Activities -$51.10M -$2.000M -$11.50M
YoY Change 2455.0% -79.8% 11400.0%
Cash From Investing Activities -$52.00M -$3.250M -$12.70M
YoY Change 1500.0% -68.96% 2016.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.800M 216.5M -400.0K
YoY Change -95.47% 92428.21% -300.0%
NET CHANGE
Cash From Operating Activities 34.30M 5.267M 7.300M
Cash From Investing Activities -52.00M -3.250M -12.70M
Cash From Financing Activities 9.800M 216.5M -400.0K
Net Change In Cash -7.900M 218.5M -5.800M
YoY Change -103.62% -42044.91% -189.23%
FREE CASH FLOW
Cash From Operating Activities $34.30M $5.267M $7.300M
Capital Expenditures -$900.0K $460.0K $884.0K
Free Cash Flow $35.20M $4.807M $6.416M
YoY Change 632.27% -49.15% -14.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1595000
CY2014Q4 us-gaap Assets
Assets
492553000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3959000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
84668000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
107760000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1698000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2147000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7002000
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
305631000
CY2014Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4734000
CY2014Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1389000
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4524000
CY2014Q1 us-gaap Other Assets Current
OtherAssetsCurrent
3703000
CY2014Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1301000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12348000
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7931000
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
231534000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
38714
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-5733000
CY2014Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
354000
CY2013Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1157000
CY2014Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4017000
us-gaap Technology Services Revenue
TechnologyServicesRevenue
46413000
us-gaap Revenues
Revenues
226210000
us-gaap Revenues
Revenues
147348000
CY2013Q4 us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
9511000
us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
39795000
us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
24409000
CY2014Q4 us-gaap Technology Services Costs
TechnologyServicesCosts
16007000
CY2013Q4 us-gaap Technology Services Costs
TechnologyServicesCosts
11881000
us-gaap Technology Services Costs
TechnologyServicesCosts
44707000
us-gaap Technology Services Costs
TechnologyServicesCosts
33835000
CY2014Q4 us-gaap Cost Of Revenue
CostOfRevenue
30416000
CY2013Q4 us-gaap Cost Of Revenue
CostOfRevenue
21392000
us-gaap Cost Of Revenue
CostOfRevenue
84502000
us-gaap Cost Of Revenue
CostOfRevenue
58244000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28519000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144082000
CY2014Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144289000
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131963000
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18952000
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10110000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
48163000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
27557000
CY2014Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10198000
CY2013Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2339000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
26851000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4613000
CY2014Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
10198000
CY2013Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
6387000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
26851000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
16937000
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129212000
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35802000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126836000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
129601000
CY2014Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
97000
CY2013Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
8000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
29000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000
CY2014Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-15000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-72000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27014000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17374000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10241000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4036000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4314000
veev Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
318000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
34495000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10288000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
5951000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3644000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2117000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
56000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-946000
CY2013Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1720000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2791000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
18731000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-43000
CY2014Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1022000
CY2013Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
774000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2943000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1552000
CY2014Q4 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-611000
CY2013Q4 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-98000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1344000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-276000
CY2014Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-76000
CY2013Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-86000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-76000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-259000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-28000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-303000
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
41000
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-21000
CY2014Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16684000
CY2013Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9417000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13151000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9852000
CY2014Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
769000
CY2013Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1750000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2189000
CY2014Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2294000
CY2013Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1224000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5859000
CY2014Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-635000
CY2013Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5254000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
17288000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
14607000
CY2014Q4 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-11000
CY2013Q4 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
433000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-9000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
758000
CY2014Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
34256000
CY2013Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
5267000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
68994000
CY2014Q4 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
103836000
CY2013Q4 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
4315000
CY2014Q4 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
52677000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
472000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12149000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1561000
us-gaap Payments For Software
PaymentsForSoftware
1013000
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
253000
CY2013Q4 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
5000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-9000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
2000
CY2014Q4 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-52022000
CY2013Q4 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3250000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
5951000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-262785000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-16708000
CY2013Q4 veev Proceeds From Stock Options Early Exercised
ProceedsFromStockOptionsEarlyExercised
158000
veev Proceeds From Stock Options Early Exercised
ProceedsFromStockOptionsEarlyExercised
225000
CY2014Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2102000
CY2013Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
95000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4314000
CY2013Q4 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
216263000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
34495000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
215734000
CY2014Q4 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
7698000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
18731000
CY2014Q4 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9800000
CY2013Q4 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
216516000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
63491000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
216431000
CY2014Q4 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-15000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-72000
CY2014Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7981000
CY2013Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
218533000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-130372000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
225251000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
140116000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38608000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31890000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
257141000
CY2014Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
477000
CY2013Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
4998000
us-gaap Income Taxes Paid
IncomeTaxesPaid
5101000
us-gaap Income Taxes Paid
IncomeTaxesPaid
14984000
CY2014Q4 veev Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
191000
CY2013Q4 veev Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
-46000
CY2014Q4 veev Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
87000
CY2013Q4 veev Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
212000
veev Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
460000
CY2013Q4 veev Initial Public Offering Costs Incurred But Not Yet Paid
InitialPublicOfferingCostsIncurredButNotYetPaid
805000
veev Initial Public Offering Costs Incurred But Not Yet Paid
InitialPublicOfferingCostsIncurredButNotYetPaid
1473000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the condensed consolidated financial statements and the notes thereto. These estimates are based on information available as of the date of the condensed consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Significant items subject to such estimates and assumptions include, but are not limited to: </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:'Wingdings 2';font-size:10pt;">&#151;</p></td> <td valign="top" style="width:96.67%;"> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the best estimate of selling price of the deliverables included in multiple-deliverable revenue arrangements; </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;;font-family:'Wingdings 2';font-size:10pt;">&#151;</p></td> <td valign="top" style="width:96.67%;"> <p style="margin-bottom:0pt;margin-top:6pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the fair value of assets acquired and liabilities assumed for business combinations;</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;;font-family:'Wingdings 2';font-size:10pt;">&#151;</p></td> <td valign="top" style="width:96.67%;"> <p style="margin-bottom:0pt;margin-top:6pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the valuation of short-term investments and the determination of other-than-temporary impairments;</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;;font-family:'Wingdings 2';font-size:10pt;">&#151;</p></td> <td valign="top" style="width:96.67%;"> <p style="margin-bottom:0pt;margin-top:6pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the valuation of building and land;</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;;font-family:'Wingdings 2';font-size:10pt;">&#151;</p></td> <td valign="top" style="width:96.67%;"> <p style="margin-bottom:0pt;margin-top:6pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the realizability of deferred income tax assets; </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:'Wingdings 2';font-size:10pt;">&#151;</p></td> <td valign="top" style="width:96.67%;"> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the fair value of our stock-based awards and related forfeiture rates; and </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:'Wingdings 2';font-size:10pt;">&#151;</p></td> <td valign="top" style="width:96.67%;"> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the capitalization and estimated useful life of internal-use software development costs. </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As future events cannot be determined with precision, actual results could differ significantly from those estimates. </p></div>
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Deferred Revenue </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Deferred revenue includes amounts billed to customers for which the revenue recognition criteria have not been met. The majority of deferred revenue primarily consists of billings or payments received in advance of revenue recognition from our subscription services described above and is recognized as the revenue recognition criteria are met. We generally invoice our customers in annual, quarterly or monthly installments for the subscription services, which are typically contracted for a term of one year or less. Accordingly, the deferred revenue balance does not generally represent the total contract value of a subscription arrangement. Deferred revenue that will be recognized during the succeeding 12-month period is recorded as current deferred revenue. </p></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Certain Risks and Concentrations of Credit Risk </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Our revenues are derived from subscription services, professional services and other services delivered primarily to the pharmaceutical and life sciences industry. We operate in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact our operating results. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents, short-term investments and trade accounts receivable. Our cash equivalents and short-term investments are held in safekeeping by large, credit-worthy financial institutions. We have established guidelines relative to credit ratings, diversification and maturities that seek to maintain safety and liquidity. Deposits in these financial institutions may exceed federally insured limits. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not require collateral from our customers and generally require payment within 30 to 60 days of billing. We periodically evaluate the collectibility of our accounts receivable and provide an allowance for doubtful accounts as necessary, based on historical experience. Historically, such losses have not been material. </p></div>
CY2014Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1881000
CY2014Q4 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
100000
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
260686000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
81000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
36000
CY2014Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
25610000
CY2014Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
16000
CY2014Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
176608000
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
17667000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
84123000
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
7958000
us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2014 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29725000
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3839000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2112000
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1394000
CY2014Q4 us-gaap Depreciation
Depreciation
400000
us-gaap Depreciation
Depreciation
1000000
CY2014Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3182000
us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
300000
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7574000
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
1100000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2260000
CY2014Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7574000
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1023000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000
CY2013Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000
CY2013Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.355
veev Increase Decrease In Effective Income Tax Rate Continuing Operations
IncreaseDecreaseInEffectiveIncomeTaxRateContinuingOperations
0.068
CY2014Q4 veev Share Based Compensation Arrangement By Share Based Payment Award Shares Subject To Repurchase Liability Recorded
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToRepurchaseLiabilityRecorded
100000
CY2014Q1 veev Share Based Compensation Arrangement By Share Based Payment Award Shares Subject To Repurchase Liability Recorded
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToRepurchaseLiabilityRecorded
500000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
25424437
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
526667
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3832160
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1140985
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
20977959
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3649536
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
19694277
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.22
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
26.64
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.13
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.63
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.12
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.16
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
4.09
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P8Y
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
726649586
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
88592429
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
539507766
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
100957561
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
507063583
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.98
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
37300000
CY2014Q4 us-gaap Share Price
SharePrice
29.78
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
26100000
CY2014Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
767413
CY2013Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35304
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
332458

Files In Submission

Name View Source Status
0001564590-14-006187-index-headers.html Edgar Link pending
0001564590-14-006187-index.html Edgar Link pending
0001564590-14-006187.txt Edgar Link pending
0001564590-14-006187-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
veev-10q_20141031.htm Edgar Link pending
veev-20141031.xml Edgar Link completed
veev-20141031.xsd Edgar Link pending
veev-20141031_cal.xml Edgar Link unprocessable
veev-20141031_def.xml Edgar Link unprocessable
veev-20141031_lab.xml Edgar Link unprocessable
veev-20141031_pre.xml Edgar Link unprocessable
veev-ex311_201410316.htm Edgar Link pending
veev-ex312_2014103110.htm Edgar Link pending
veev-ex321_201410318.htm Edgar Link pending
veev-ex322_201410319.htm Edgar Link pending